SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001263259-03-000004
Filing Date
2003-09-16
Accepted
2003-09-16 16:02:54
Documents
1
Period of Report
2003-09-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 4139
  Complete submission text file 0001263259-03-000004.txt   5817
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Issuer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 148 FULLARTEN STREET #2006 LONDON ONTARIO CANAD A6 N6A 5P3 4162134694
STILLER CALVIN (Reporting) CIK: 0001263259 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-23272 | Film No.: 03897727